What is the recommended simethicone dosage for adults, children aged 2–12 years, and infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Simethicone Dosage

For adults, the recommended dose is 180 mg (1-2 softgels) as needed after meals and at bedtime, not exceeding 2 softgels (360 mg) in 24 hours unless under physician supervision 1.

Adult Dosing

  • Standard dose: 180 mg per softgel
  • Frequency: 1-2 softgels as needed after meals and at bedtime
  • Maximum daily dose: 360 mg (2 softgels) in 24 hours without medical supervision 1
  • Administration: Swallow with water 1

Pediatric Dosing (Children 2-12 Years)

There is no FDA-approved standardized dosing for children in the available drug labeling. The evidence provided does not contain specific pediatric dosing guidelines from authoritative sources. However, research suggests simethicone has been studied in pediatric populations:

  • In endoscopy preparation studies, doses ranging from 200-1200 mg have been used in pediatric patients 2
  • A systematic review of pediatric endoscopy preparation found simethicone improved visualization without increasing adverse events 2

Important caveat: The lack of FDA-approved pediatric dosing means prescribers must rely on clinical judgment and off-label use guidelines. Consultation with a pediatric gastroenterologist or pharmacist is advisable for specific pediatric dosing.

Infant Dosing

For infantile colic, simethicone has been studied but shown no superiority over placebo 3. A randomized controlled trial of 83 infants aged 2-8 weeks found simethicone was no more effective than placebo in treating infant colic, with only 28% responding exclusively to simethicone versus 37% to placebo 3.

Critical warning for infants: Recent evidence suggests simethicone may interfere with oral lactase treatment in infants with lactose intolerance, reducing treatment efficacy 4. Avoid concurrent use of simethicone with oral lactase in infants 4.

Clinical Context

  • Mechanism: Simethicone is an antifoaming agent that reduces surface tension of gas bubbles, facilitating their elimination
  • Safety profile: Generally well-tolerated with minimal systemic absorption
  • Efficacy concerns: While widely used for gas-related symptoms, evidence for clinical benefit in infant colic is lacking 3

Important Considerations

For endoscopic procedures: When used as an adjunct to bowel preparation, doses of 200-500 mg have been effective in improving mucosal visibility 5, 6. Lower doses (200 mg) appear as effective as higher doses (1200 mg) for colonoscopy preparation 5.

Drug interactions: Potential interference with lactase efficacy in infants has been documented 4, suggesting caution with concomitant medication use in this population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.